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ABSTRACT
(

Objective: This study was designed to study the inappropriate medication utilization

in patients aged 65 years or older residing in a long term care facility; to examine
patterns in the use of inappropriate medications during the stay in the facility; and to
determine predictors of inappropriate medication use.
Design: Retrospective, cross-sectional study
Methods: We used the Systematic Assessment of Geriatric Drug Use via

Epidemiology (SAGE) database that includes data from all Medicaid/Medicare
certified nursing homes located in 5 US states. We examined data collected with the
federally mandated Minimum Data Set along with the sociodemographic, clinical and
treatment information during the period October 1995 to September1996 (n =44,562).
Measurements: Inappropriate medication was defined according to Beers' criteria.

Use of inappropriate medication was determined at admission and at ninety days. We
calculated incidence of discontinuation, initiation, and continuance of these
medications over the ninety-day period in the nursing home. A logistic regression
model provided estimates of Odds Ratio (OR) for the predictors of inappropriate use
of drugs.
Results: Thirt-three percent of the residents were receiving at least one inappropriate

medication on admission to the long term care facility. Of the 29,082 remaining in
long term care facility ninety days after admissic:>n, 16% on an inappropriate
medication at admission had the medication discontinued, while 18% of non-users at
admission initiated an inappropriate agent during the 90 days, a net result of 39%
using an inappropriate agent at 90 days. The number of medications taken by the

II

(

patient, race, age and level of cognitive impairment were found to be associated with
the use of inappropriate medications.
Discussion: Overall use of inappropriate medication increased significantly during the

first 90 days of residence in a long term care facility. Inappropriate use of long acting

'

benzodiazepines and analgesics was of particular concern. These findings highlight
the need for careful patient medication regimen assessment and medication
prescribing upon long term care admission.
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PREFACE
This work has been prepared in accordance with the format for thesis preparation, as
outlined in section 11-3 of the Graduate Manual of the University of Rhode Island.
Contained within is a body of work divided in two sections.
Included within Section I is the thesis, containing the findings of the research which
comprise this thesis.
Section II is comprised of an appendix containing SAS programs
Section ID contain the Minimum Data Set (MDS), a comprehensive instrument
designed to assess resident health status and functional levels.
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SECTION I
(

Inappropriate medication use in an elderly nursing home population

1

ABSTRACT

.(
Objective: This study was designed to study the inappropriate medication utilization

in patients aged 65 years or older residing in a long term care facility; to examine
patterns in the use of inappropriate medications during stay in the facility; and to
determine predictors of inappropriate medication use.
Design: Retrospective: cross-sectional study
Methods: We used the Systematic Assessment of Geriatric Drug Use via

Epidemiology (SAGE) database that includes data from all Medicaid/Medicare
certified nursing homes located in 5 US states. We examined data collected with the
federally mandated Minimum Data Set along with the sociodemographic, clinical and
treatment information during the period October 1995 to Septemberl996 (n = 44,562).
Measurements: Inappropriate medication was defined according to Beers' criteria.

Prescribing of inappropriate medication was determined at admission and at ninety
days. We calculated inaidence of discontinuation, initiation, and continuance of these
medications over the ninety-day period in the nursing home. A logistic regression
model provided estimates of Odds Ratio (OR) for the predictors of inappropriate
prescribing.
Results: Fifty-two percent of the residents were receiving inappropriate medication on

admission to the long term care facility. Of the 29,082 remaining in long term care
facility ninety days after admission, 8% on an inappropriate medication at admission
had the medication discontinued, while 23% of non-users at admission initiated an
inappropriate agent during the 90 days, a net result of 51 % using an inappropriate
agent at 90 days. The number of medications taken by the patient, race, age and level

2

of cognitive impairment were found to be associated with the prescribing of
inappropriate medications.
Discussion: Overall prescribing of inappropriate medication increased significantly
during the first 90 days of residence in a long term care facility. Inappropriate
prescribing of long acting benzodiazepines and analgesics was of particular concern.
These findings highlight the need for careful patient medication regimen assessment
and medication prescribing upon long term care admission.

3

INTRODUCTION
Individuals who are 65 years of age or older now constitute 11 % of the total
United States population. By 2030, more than 64 million people will be over age 65,
constituting 21 % of the population [1]. Of patients aged 85 years and older, 20% are
living in long term care (LTC) facilities [2]. With the aging of the population and
changes in the American family, nursing homes have taken on an increasingly
prominent role in the medical care of disabled older people [3]. In 1990,
approximately 1.56 million people over age 65 resided in the 15,600 long term care
nursing facilities in the United States (a rate of 53.3/1000 elders) [4]. The increasing
importance of long term care has been realized due to changes in the delivery of health
care services.
Medicare and Medicaid were enacted in 1965. Prior to this, there were
essentially no federal standards governing nursing home care. By the early 1980s,
problems in the quality bf nursing home care arose. Reacting to this, the Health Care
Financing Administration (HCF A) prepared draft guidelines for nursing home
regulation. In late 1983, Congress asked the Institute of Medicine (IOM) to conduct a
two-year study and make recommendations for improving the quality of care in
nursing facilities; a summary of this report was published in 1986 [5]. Finally,
continuing problems of inadequate care and ineffective regulation lead the Unites
States Congress to pass the Nursing Horne Refo~ Amendments as part of the
Omnibus Budget Reconciliation Act (OBRA) of 1987. It produced an extensive set of
reforms in nursing home care. Regulations promulgated as a result of the act included
new requirements on quality of care, resident assessments, care planning and the use
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of neuroleptic drugs. Many reviews such as the licensure of facilities, inspection of
care, ombudsman programs and government regulations of various kinds also evolved
to improve the quality of nursing home care. As a result of these legislative initiatives,
nursing home care in skilled and intermediate care facilities became the major publicly
subsidized form of long term care for the functionally impaired elderly [5].
Elderly nursing home residents tend to utilize· more medications than any other
group and the utilization of drugs in this setting has come under increased scrutiny [3] .
Due to social, psychological and physiological factors, the elderly utilize more
medication than younger people and may suffer more adverse effects from medication
use. They are often prescribed an average of four to eight medications per day [6].
One of the major problems in the elderly concerning medications is the use of
inappropriate drugs. An inappropriate drug (or intervention) is considered as one,
which offers greater risk than benefit taking into consideration its adverse effects.
Usually, the drug (or initrvention) might have an existing safer alternative or that a
preferable (usually newer) medication might be available [7]. Since some of the drugs
might be appropriate under patient specific conditions, inappropriate use should be
referred to as 'potentially inappropriate' use. A review of literature on appropriateness
of prescriptions revealed that between 7% to 51% of psychoactives, 22% to 90% of
anti-infectives, and 33% to 71 % of GI drugs were prescribed inappropriately to the
elderly [8] . Inappropriate prescribing prevalence could vary from 7.5% in office
based practice to 40% in nursing homes [9] . Many factors contribute to prescribing of
inappropriate drugs in nursing homes. A study carried out by Gupta et al on
Louisiana's 19,932 ICF (Intermediate Care Facility) beneficiaries revealed that the
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number of physicians, n~mber of pharmacies used and the number of drugs prescribed
were the factors responsible for higher inappropriate medication use (10].
In 1991, Beers et al. developed explicit criteria that defined the use of
inappropriate medications for the elderly. These criteria were developed by a
consensus of internationally recognized experts in geriatric medicine for the elderly
population residing in nursing facilities. They were later updated in 1997 (7, 11].
Beers high severity drugs have been included in the recent HCFA interpretive
guidelines for nursing facilities effective July 1,1999, in the category of unnecessary
drugs while the low severity drugs are a part of the drug therapy review process
conducted by a consultant pharmacist every month (12]. HCFA utilizes these
guidelines as well as nursing facility survey procedures to guide surveyors inspecting
nursing facilities in monitoring compliance with regulations. The Beers criteria have
been extensively used by researchers to study the prevalence of inappropriate
medication use among the elderly population (10, 13] [14, 15] (16, 17] (18, 19].
Most of these studies focussed on the percentage use but none of them had
looked at the pattern of use during the stay in the nursing home. This study was
designed to examine the rates of initiation, discontinuation, and continuance of
inappropriate medication using the Beers criteria during the first 90 days of stay in the
nursing facility for patients aged 65 years of age or older. The study also identified
sociodemographic characteristics and predictors of inappropriate medication use.

6

METHODS

(
Data source

We used the Systematic Assessment of Geriatric drug use via Epidemiology
(SAGE) database for the study. Briefly, SAGE is a population-based, multi-linked
database that includes computerized data collected as part of the HCFA's Multistate,
Nursing Home Case-mix and Quality Demonstration Project. This database includes
patient information collected with the minimum data set (MOS), drug prescription
data, organizational data on nursing home providers and Medicare claims data. Since
1992, nursing home staff in all Medicare and Medicaid facilities of five states (Kansas,
Maine, Mississippi, New York, and South Dakota) have evaluated patients using the
Resident Assessment Instrument, which includes a more than 350-item Minimum Data
Set (MOS). This is a comprehensive instrument designed to assess resident health
status and functional levels [20].
MOS Data - Th~MDS includes sociodemographic information, numerous
clinical items ranging from the degree of functional dependence to cognitive
functioning, and all clinical diagnoses. It also includes an extensive array of signs,
symptoms, syndromes, and treatments being provided to the resident [20, 21]. In
addition to the MOS data, nursing staff recorded up to 18 different medications
received by each resident during the assessment. Drug information included brand
and/or generic name, dosage, route, and frequen.cy of administration [22-24]. Drugs
were coded according to the National Drug Coding (NDC) system and the
MediSpan® system was used to translate these NDC codes into usable therapeutic
class and sub-class information [24].

7

The SAGE datab.ase has been described in detail elsewhere [22-24].

It has

I

been previously documented that the SAGE database has excellent validity, and the
database has proved a useful and reliable tool for pharmacoepidemiologic research
[21] [25] [26].

Sample
We identified 44,562 people admitted to the 1492 nursing homes in five states
(Kansas, Maine, Mississippi, New York, and South Dakota) during October1995 and
September1996 and who were greater than 65 years of age. All the nursing homes
completed a nursing home assessment for each resident within 14 days of admission,
30 days later and quarterly thereafter. For the baseline evaluation, we chose 44,562
people who had an initial assessment at admission. Of these 44,562 people, we
identified 29,082 people who had a follow up assessment done at 90 days.

Outcome
The concepts o~.appropriateness and appropriateness criteria have often been
used in geriatric practice or health services research. There are several definitions of
appropriateness defined by most clinicians and health service researchers [27]. For the
purpose of this study, the following definition of appropriateness within the risk
benefit concept was used, "The use of a drug (or any intervention) is inappropriate
when its potential risk outweighed its potential benefits".
In 1991, Beers .et al operationalized the c;iefinition when he published the first
list of explicit criteria identifying inappropriate medications in nursing home residents
[7]. In 1997, the criteria were updated and expanded. The new criteria revisited the
old criteria, included new products and incorporated new information available in the
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scientific literature and also assigned a relative rating of severity to each criteria.
These criteria defined medications that should generally be avoided in the elderly,
doses or frequencies of administrations that should generally not be exceeded, and
medications that should be avoided in older persons known to have any of the several
comorbidities. Each of the criteria was also assigned a severity rating. Severity was
defined conceptually as combinations· of both the likelihood that an adverse outcome
would occur and the clinical significance of that outcome should it occur.
For the purpose of this study, inappropriate medications for elderly patients
constituted a subset of the Beers updated criteria (Tablel. Final Criteria: Independent
of Diagnoses) [11]. Forty-three inappropriate medications that apply to the Beers final
criteria were selected. These were categorized into therapeutic classes based on the
Beers criteria and the Medispan coding. For this study, a resident was labeled as

- ·,. :
having received an inappropriate medication if they had used one or more of the drugs
mentioned in the Beers ~teria.
Outcome measures for this study included baseline evaluation of inappropriate
medication use. This gave the percentage use of drugs at admission to the nursing
facility. For the 29,082 people who had a 90-day assessment, the incidence of
discontinuation and initiation of each of the inappropriate medications was calculated.
Discontinuation referred to those who took the drug at baseline but discontinued the
drug during their first 90 days of stay in long ter_m care (LTC) facility. Initiation
referred to those who did not take the drug at baseline but initiated the drug during
first 90 days of stay in LTC facility.

9

Clinical measures

(

For the purpose of logistic modeling, two clinical measures were used. To
assess the degree of cognitive impairment, the Cognitive Performance Scale (CPS)
was used [28]. CPS is a well-validated scale with scores ranging from 0 (intact
cognition) to 6 (severe dementia). CPS scores correlate well with the Mini-Mental
State Examination (MMSE) and have been shown to be suitable for outcomes research
[28] [29]. Each resident was categorized as having no or minimal cognitive
impairment (CPS 0 or 1; MMSE equivalent is 24 and 23), moderate cognitive
impairment (CPS 2, 3 or 4; MMSE equivalent is 17, 13 and 6), or severe cognitive
impairment (CPS 5 or 6; MMSE equivalent is 3 and 2) [29] [28].
The Activities of Daily Living (ADL) scale was used to assess resident's
dependency in the areas of eating, dressing, toileting, bathing, locomotion,
transferring, and incontinence [30]. The ADL score ranged from mild (ADL score 0
or 1), moderate (ADL srore 2 or 3), or severe (ADL score 4 or 5) dependence.

Analysis
Descriptive analyses were carried out using Statistical Analysis Software (SAS
Ver 6.12). For the baseline evaluation,% inappropriate medication use was
determined for the 44,562 residents who had an admission assessment. To calculate
the discontinuation and initiation rates for the 43 different medications taken by the
29,082 residents during the 90-day period, cross.tabulations between the usage of
these medications at admission and at 90 days were designed.
Using a logistic model, we evaluated the relation between demographic and
clinical variables and the use of drugs during the 90 days of stay in the nursing home.
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Missing data were also modeled and it accounted for less than 1% in the model. Odds
(

Ratio and 95% Confidence Intervals were estimated from the model.

RESULTS
Out of 44,562 nursing home residents, 22,234 were receiving potentially
inappropriate medication on admission to a long term care facility. The top five
frequently prescribed medications included digoxin (in doses> 0.125mg, 22.1 %), iron
supplements (in doses> 325 mg of ferrous sulphate, 10.3%), propoxyphene (10.1 %),
lorazepam (4.9%) and temazepam (2.7%). (Refer to Tablel) Among the high severity
medications, digoxin (in doses> 0.125mg) was most frequently prescribed. Thirtythree percent of the inappropriate medications were of high severity. Inappropriate
use of antianxiety agents including the long acting benzodiazepines was noted in 9.3%
of the residents. This category included lorazepam, alprazolam, oxazepam, triazolam,
- .J... _'.

diazepam, chlordiazepoxide and meprobamate. Prescribed cardiovascular agents
(disopyrarnide, digoxin.,'liclipyridamole, methyldopa and reserpine) deemed
inappropriate was about 23.4%.
Table 2 presents the demographic and clinical characteristics of the residents
evaluated after 90 days in the long term care facility. The female population was more
than two times larger than the male population. About 80% of the sample under study
was 75 or more years of age. Whites were a majority while the black population was
about 7%. Seventy-seven percent of the residen~s under study were admitted from the
hospital, while about 13% were admitted from the home.
A review of the clinical characteristics indicated that about 51 % of the
population had moderate dependency in the areas of eating, dressing, toileting,
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bathing, locomotion, transferring, and incontinence, while 33% had severe
dependency. A majority of the residents had either minimal or moderate level of
cognitive impairment. Residents with minimal or no cognition formed about 11 % of
the study population.
The pattern of use of inappropriate medication during the 90 days is presented
in Table 3 in the form of discontinuation and initiation. For example, there were 2701
users at admission of propoxyphene. After ninety days, 636 (23.6%) residents
discontinued its use. Out of the 26,381 non-users of propoxyphene, during the 90 day
period, 1345 patients were prescribed a new propoxyphene prescription.
The discontinuation rates show that out of the 43 different drugs, the
inappropriate drugs that were discontinued the most included promethazine (56.2% ),
meperidine (54.8%) and dexchlorpheniramine (54.6% ). Of the 43 different Beers
drugs, propoxyphene, lorazepam, amitryptiline and combinations, digoxin (in doses>
0.125mg) and iron supp1ements were used most frequently at admission. But, on
average, 17% of these drugs were discontinued during the first 90 days. For example,
of the 6490 residents on digoxin at admission, 6218 residents were still on the drug
after 90 days. Thus, very few people taking inappropriate drugs at admission tended
to discontinue the drug during their initial period of stay in the nursing home.
Overall, initiation of inappropriate drugs was found to be high (about 23% ).
The top five drugs initiated the most were propo_xyphene (5.1 %), iron supplements
(5%), digoxin (3.4%), lorazepam (2.8%), and hydroxyzine(l.6%). Central nervous
system drugs (including anti-anxiety agents, antidepressants, and hypnotics) and
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analgesics were the two therapeutic categories with overall high initiation rates of
8.8% and 5.8% respectively.
Table 4 presents the results for the logistic regression analysis of our data.
Females were 1.2 times more likely than males to be prescribed an inappropriate drug
after controlling for race, age, number of medications taken and clinical status (95%
confidence interval [CI], 1.1-1.2). It was found that as the number of medicatfons
taken by resident increased, the likelihood of being prescribed an inappropriate
medication also increased. Residents on nine or more medications were 6 times more
likely than those on one to three medications to be taking an inappropriate drug after
other factors were controlled (95% confidence interval [CI], 5.5-6.4). Patients
admitted from hospitals were more likely to be prescribed an inappropriate medication
than those admitted from a private home, nursing home or other facility.
- ·"-"

It was also observed that patients who had severe dementia were less likely to
be taking an inappropriate medication as compared to those who had no cognitive
impairment (odds ratio OR, 0.7; 95% CI, 0.6-0.8). Age was also an important
predictor of inappropriate medication. The likelihood of receiving an inappropriate
medication increased as the age increased from 65 years to 85 years. Residents with
85 or more years of age were 1.4 times more likely to be receiving an inappropriate
medication than those who were 65-74 years of age (95% confidence interval [Cl],
1.3-1.5). Resident dependencies in the

activitie~

of daily living were not found to be

an important predictor of the use of inappropriate medication.
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Thus, the risk of .receiving an inappropriate medication were higher for those
(

people who were 85+ years of age, white, female, admitted from the hospital, having
good cognitive ability and had received a higher number of medications.

14

DISCUSSION

(
Using a population-based sample of nursing home residents in five states for a
one-year period, we found that prescribing of inappropriate medication had been
significantly higher during the first 90 days of residence in a long term care facility
than prior to admission. Inappropriate prescribing of long acting benzodiazepines,
analgesics and cardiovascular agents was of particular concern. Several studies
involving the elderly population have also obtained similar results [9, 10, 15]. We
used data of long term care facilities in five different states: Newyork, Kansas, Maine,
Mississippi, and South Dakota. Due to heterogeneity of the group, it seems
appropriate to generalize the results of the study to the older population residing in
nursing homes.
Many factors contribute to prescribing of inappropriate drugs in nursing
homes. Infrequent phy;f~ian visits and lack of formal training for health care
professionals in long term care are contributing factors [10]. Low discontinuation
rates of inappropriate medication show that nursing facilities need to focus on a
careful patient medication regimen assessment and medication prescribing upon long
term care admission. The pattern of discontinuation and initiation of inappropriate
drugs suggests that a regular review of prescribed therapy is essential, allowing the
unnecessary drugs to be reevaluated and potentially discontinued.
We found most of the people admitted fr~m the hospital were receiving
inappropriate medications. One reason for this might be that these residents were
already on the drugs when they were admitted and drug therapy was not changed
during their hospitalization. Polypharmacy has been shown in various studies to
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influence patient susceptibility to adverse drug reactions [31]. Our study was
consistent with this finding. The number of drugs prescribed served as a surrogate for
polypharrnacy. We also found that the very old population took a large number of
inappropriate drugs. It may be that older residents had more illness and more severe
conditions but it can also indicate that physicians tend to be less cautious in
prescribing to the older persons.
Some of the limitations of our study included the possibility of an incomplete
listing of drugs for residents receiving more than 18 drugs and the possibility of
inaccurate reporting of drug use. For example, people with atrial fibrillation needing
higher doses (>0.125mg) of digoxin could be reported as inappropriately prescribed
although higher doses of 0.25 mg might be required to maintain a therapeutic drug
concentration and rate lowering cardiac effect. Another possibility of inaccurate

·.

--......

reporting might be that drug data were collected alongwith the Minimum Data Set
'

(MDS) assessments 14 days after patient admission, after 30 day and quarterly
thereafter. Therefore, information on short-term use medications may not be collected
if the prescription was ordered beyond 7-15 days from the MDS administration.
The MDS data has been questioned as far as clinical measures and functional
outcomes are concerned [32, 33]. However, we used clinical measures previously
validated to be reliable and accurate [21, 29, 30, 34-36]. In addition to the issue of
accuracy and validity, there are methodological l>roblems inherent in the use of a cross
sectional design. For example, we do not have patient data preceding the initial MDS
assessment but we do know the reason for nursing home admission, and whether the
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patient was previously Hving at home, in another nursing facility, or discharged from

(
the hospital.
The Beers criteria have been widely used by researchers as well as regulatory
accreditation groups and clinicians, as an indicator of quality prescribing in the elderly
population. However, it must be realized that in a limited number of patient specific
cases, some of the medications on this list may be appropriately prescribed. We used
the new updated criteria for the study. Infact, this is one of the first studies using the
new updated criteria. Most of the studies have used the original criteria that were
developed in 1991 (3, 10, 14, 15, 17]. Some medications on the list of inappropriate
drugs developed as part of the old criteria may pose a greater risk and cause more
harm than others. The new criteria aided in classifying inappropriate drugs into high
severity and low severity depending on the problems that might arise because of its
use. Beers high severitY'ctrugs have now been included in the recent HCFA
'

interpretive guidelines fer nursing facilities effective July 1,1999. Future research into
the validation of the criteria is also essential with the advent of new drugs, therapies
and treatments.
Although this study was cross sectional, it should aid health care providers and
policy makers in understanding some of the contributory factors for inappropriate
prescribing. The SAGE (Systematic Assessment of Geriatric Drug Use via
Epidemiology) database offers an excellent tool .for conducting research on the nursing
home population. Further studies are needed to explore the patient diagnoses and
outcomes associated with inappropriate prescribing to better understand the nature of
the problem. Some studies have shown that geographic variation and the type of

l
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doctor are also important determinants of prescribing inappropriate drugs (10]. These

(
factors were beyond the scope of our study.
The nursing home industry is often blamed for not providing optimum care to
its residents. Thus, it becomes essential to provide sufficient knowledge to the health
care providers about the inappropriate drugs and their adverse effects and efficient
0

mechanisms for reviewing medication use and offering advice to reduce risk.
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Table1. The use of Inappropriate medication for Individuals aged 65 years and older
on admission to a long term care facility during Oct 1995 to June 1996, using the Beers criteria•

Inappropriate medication•

% receiving
High
medication• at
Severity
Medication• admlsslon(n=44,562)

Propoxyphene
lndomethacln
Phenylbutazone
Pentazoclne
Meperldlne

No
No
No
Yes
Yes

10.1
0.6
0.0
0.1
0.6

Antispasmodic agents

Dlcyclomine
Hyoscyamine
Propantheline
Beliadona alkaloids

Yes
Yes
Yes
Yes

0.2
0.2
0.0
0.1

Ant/emetics

Trimethobenzamide

No

0.3

Muscle Relaxants

Methocarbamol
Carisoprodol
Chlorzoxazone
Metaxalone
Cyclobenzaprine

No
No
No
No
No

0.2
0.1
0.1
0.0
0.3

Oxybutynin

No

1.4

Lorazepamt
Oxazepamt
Alprazolamt
Diazepam
Chlordiazepoxlde and comb.
Meprobamate

No
No
No
Yes
Yes
Yes

0.1
0
0.1
1.0
0.3
0.2

Antidepressants

Amitryptlllne and comb.
Doxepln

Yes
Yes

2.5
0.8

Hypnotics

Flurazepam
Trlazolamt
Temazepamt
Zolpldemt

Yes

0.3
0.1
1.2
1.0

Therapeutic Categories

Analgesics

'

Gastrointestinal agents

Urinary Antispasmodics

-..

Central Nervous System Drugs

Ant/anxiety agents
"tj..

No
No
No

(Contd ..)
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Table1. The use of Inappropriate medication for lndlvlduals aged 65 years and older
on admission to a lon-2_term care facll.!!l_durln-2_ Oct 1995 to June 1996, using the Beers criteria•
Therapeutic Categories

Cardiovascular agents

'

Inappropriate medication•

% receiving
High
medication• at
Severity
Medication• admlsslon(n=44,562)

Dlsopyramlde
Dlgoxlnt
Dlpyrldamole

Yes
Yes
No

0.2
5.2
1.1

• Yes
No

0.5
0.6

Antlhypertenslve agents

Methyldopa
Reserpine

Antldlabetlc agent

Chlorpropamlde

Yes

0.2

Antlhlstamlnlc agents

Chlorphenlramlne
Dlphenhydramlne
Hydroxyzine
Cyproheptadlne
Promethazlne
Trlplennamlne
Dexchlorphenlramlne

No
No
No
No
No
No
No

0.4
2.5
1.7
0.4
1.0
0.0
0.0

Hematological agents

Iron Supplementst

No

5.1

Anti Platelet Agents

Tlclopldlne

Yes

0.0

..

..

*as defined by Beers [Beers, M. H. (1997) . "Explicit cntena for determining potentially
inappropriate medication use by the elderly. An update." Arch Intern Med 157(14): 1531-6.]
tDose limits apply
- JJ;,_..
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Table 2. Demographic and clinical characteristics of
residents aged 65 years and older residing In the nursing
facility for 90 days during Oct 1995 to June 1996

Characteristics

% of residents

n=29082

Gender:
Female
Male

68.7
31.2

Age:
65-74
75-84
85+

17.7

40.9
41.2

Race:
American Indian/ Alaska Native
Asian/Pacific Islander
Black, not of Hispanic origin
Hispanic
White, not of Hispanic origin
Admitted from :
Home
Nursing Home
Hospital
Other

..... :.} ,/...!.

'fi,'

2.0
0.8
6.8
1.6
84.1

13.4
3.8
77.0
5.6

Activities of daily living scale*:
0 - 1 (Mild)
2 - 3 (Moderate)
4 - 5 (Severe)

7.5
51 .5
33.9

Cognitive Performance Scale § :
O - 1 (Minimal)
2 - 4 (Moderate)
4 - 6 (Severe)

41.6
46.3
11.5

*as defined by Beers [Beers, M. H. (1997). "Explicit cntena for determining potentially
inappropriate medication use by the elderly. An update." Arch Intern Med 157(14): 1531-6.]
:f: Summary score for the .Activities of Daily living as measured on the AOL scale
§ Cognitive Performance Scale (CPS) as measured on .the Fries and Morris CPS Index
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Table 3 - Incidence of Discontinuation and Initiation of inappropriate drugs during transition
from ambulatory to LTC (long term care) facility during the first 90 days of stay
in L TC facility for patients aged 65 years or older.

Therapeutic Categories

Analgesics

Beers Drugs*

Propoxyphene
lndomethacin
Phenylbutazone
Pentazocine
Meperidine

DISCONTINUATION*
Users at
% Users who
admission(n) discontinued

.

INITIATION§
Non-Users at % Non users
admission(n) who initiated

2701
157
0
19
104

23.6
39.5
0
31 .6
54.8

26381
28925
29082
29063
28978

5.1
0.5
0
0
0.3

N
N

Gastrointestinal agents
Antispasmodic agents

Dicyclomine
Hyoscyamine
Propantheline
Belladona alkaloids

50
58
12
32

22
18.9
25
28.1

29032
29024
29070
29050

0.1
0.1
0
0.1

Antiemetics

Trimethobenzamide

58

46.6

29024

0.4

Muscle Relaxants

Methocarbamol
Carisoprodol
Chlorzoxazone
Metaxalone
Cyclobenzaprine

59
25
13
1
68

35.6
48
38.5
0
36.8

29023
29057
29069
29081
29014

0.1
0.1
0
0
0.1

Urinary Antispasmodics

Oxybutynin

442

14.3

28640

0.6
(Contd ... )

Table 3 - Incidence of Discontinuation and Initiation of inappropriate drugs during transition
from ambulatory to LTC (long term care) facility during the first 90 days of stay
in L TC facility for patients aged 65 years or older.

Therapeutic Categories

Beers Drugs*

INITIATION§
Non-Users at % Non users
admission(n) who initiated

DISCONTINUATION*
Users at
% Users who
admission(n) discontinued

Central Nervous System Drugs
N

w

Antianxiety agents

Lorazepam
Oxazepam
Alprazolam
Diazepam
Chlordiazepoxide and comb.
Meprobamate

31
2
28
243
73
62

29
100
35.7
22.2
31.5
46.8

Antidepressants

Amitryptiline and comb.
Doxepin

725
218

Hypnotics

Flurazepam
Temazepam
Zolpidem
Triazolam

46
307
220
34

.

29051
29080
29054
28839
29009
29020

0.03
0.01
0.09
0.4
0.1
0.2

21.2
15.14

28357
28864

1.4
0.5

43.5
29.9
30.9
35.3

29036
28775
28862
29048

0.1
0.7
0.7
0.1
(Contd ... )
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Table 3 - Incidence of Discontinuation and Initiation of inappropriate drugs during transition
from ambulatory to LTC (long term care) facility during the first 90 days of stay
in LTC facility for patients aged 65 years or older.

Therapeutic Categories

Beers Drugs*

Cardiovascular agents

Disopyramide
Digoxin
Dipyridamole

60
1487
312

13.3
13.7
14.4

29022
27595
28770

0
1.4
0.3

Antihypertensive agents

Methyldopa
Reserpine

158
169

17.1
31.4

28924
28913

0.1
0.2

Antidiabetic agent

Chlorpropamide

68

22.1

29014

0.1

Antihistaminic agents

Chlorpheniramine
Diphenhydramine
Hydroxyzine
Cyproheptadine
Promethazine
Triplennamine
Dexchlorpheniramine

131
678
492
98
178
1
11

51 .2
39.4
33.54
36.7
56.2
0
54.6

28951
28404
28590
28984
28904
29081
29071

0.6
2.3
1.6
0.5
0.7
0
0

Hematological agents

Iron Supplements

1521

12

27561

3

Anti Platelet Agents

Ticlopidine

0

0

29082

0

DISCONTINUATION*
% Users who
Users at
admission(n) discontinued

INITIATION §
Non-Users at % Non users
admission(n) who initiated

N

.i::-

*as defined by Beers [Beers, M. H. (1997) . "Explicit criteria for determining potentially
inappropriate medication use by the elderly. An update." Arch Intern Med 157(14): 1531-6.)
:t: Discontinuation - refers to those who took the drug at baseline but
discontinued the drug during first 90 days of stay in LTC facility
§ Initiation - refers to those who did not take the drug at baseline but
initiated the drug during first 90 days of stay in LTC facility

(

Table 4 - Logi:;tic Regression Model for determining predictors of inappropriate
medication prescribing,using Beers criteria* for residents aged 65 years or older
after 90 days of stay in nursing home
Predictor Variables
Adjusted Odds Ratio (95% C.I.)
Crude Odds Ratio
Age
65 - 74 (referrent)
1.0
75-84
1.0
1 (0.9-1.0).
0.9
0.9 (0.9-1.0)
85 +
Race
White (referrent)
1.0
Black
0.6
0.7 (0.6-0.8)
Other
0.7
0.7 (0.7-0.9)
Gender
Male (referrent)
1.0
1.2 (1.1-1.2)
Female
1.2
Admitted from
Hospital
1.2 (1 .1-1.3)
1.3
Other (referrent)
1.0
No. of Total Medications Taken
1-3 (referrent)
1.0
4-5
1.7 (1 .6-1.9)
1.4
6-8
2.2
2.4 (2.2-2.6)
2.1
3.5 (3.2-3.8)
9+
Cognitive Performance Scale
lntacVMild (referrent)
1.0
Moderate
0.7 (0.6-0.7)
0.6
Severe
0.6 (0.5-0.6)
0.5
Activities of daily living scale
Mild limitations (referrent)
1.0
Moderate limitations
1.4
1.3 (1.1-1.4)
Dependent
1.1
1.2 (1.1-1.3)
*as defined by Beers [Beers, M. H. (1997). "Explicit criteria for determining potentially
inappropriate medication use by the elderly. An update." Arch Intern Med 157(14): 1531-6.]
:t: Summary score for the Activities of Daily living as measured on the ADL scale
§ Cognitive Performance Scale (CPS) as measured on the Fries and Morris CPS Index
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(
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APPENDIX
PROGRAMl
PURPOSE : This program lists the drugs corresponding to the Medispan drug
coding.
options obs=max fmtsearch=(work library std_anal.hcfafmts std_anal.mrh_fmts
std_anal.mmarlcmx);
%let alllist = dmpers dmdate nd: ;
data tmplsd;
set sagea.sd (in=a keep=&alllist);
if 'O 1-Jan-1996 'd<=dmdate<='31-dec-1996'd;
data tmplny;
set sagea.ny (in=a keep=&alllist);
if '01-Jan-1996'd<=dmdate<='31-dec-1996'd;
data tmplms;

t;.~

set sagea.ms (in=a keep=&alllist);
if 'O 1-Jan-1996'd<=dmdate<='31-dec-1996'd;
data tmplme;
set sagea.me(in=a keep=&alllist);
if 'O 1-Jan-1996'd<=dmdate<='31-dec-1996'd;
data tmplks;
set sagea.ks(in=a keep=&alllist);
if 'O 1-Jan-1996'd<=dmdate<='3 l-dec-1996'd;
data tmpl; set tmplsd tmplny tmplms tmplme tmplks;

31

vartmpl='
(

'·

'

*Preparation for using MEDISPAN codes;
%let mdsa = ndOlmds nd02mds nd03mds nd04mds nd05mds nd06mds
nd07mds nd08mds nd09mds ndlOmds ndl lmds nd12mds
nd13mds ndl4mds nd15mds nd16mds ndl 7mds nd18mds;
%let dsc=ndOldsc nd02dsc nd03dsc nd04dsc nd05dsc nd06dsc
nd07dsc nd08dsc nd09dsc ndlOdsc ndl ldsc nd12dsc
nd13dsc ndl4dsc ndl5dsc nd16dsc ndl 7dsc nd18dsc;
array ndmds {18} &mdsa;
array ndsc {18} &dsc;
array ndtwo {18} ndtwo01-ndtwo18;
array ndfour {18} ndfour01-ndfour18;
.. . .
array ndsix {18} ndsix01-ndsix18;
array ndeig {18} ndeig01-ndeig18;
do i=l to 18;
ndtwo{i} = int(ndmds{i}/100000000);
ndfour{i} = int(ndmds{i }/1000000);
ndsix{i} = int(ndmds{i}/10000);
end;
acode=O;bcode=O;ccode=O;dcode=O;
ecode=O;fcode=O;gcode=O;hcode=O;icode=O;
jcode=O; kcode=O; lcode=O; mcode=O; ncode=O;
ocode=O;pcode=O;qcode=O;
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DO i = 1TO18;
desc=ndsc {i };
if ndtwo{i} = 65 or ndtwo{i }=66 or ndtwo{i }=49 or
ndtwo{i} = 75 or ndtwo{i }=50 or ndtwo{i }=54 or ndtwo{i }=60 or
ndtwo{i} = 57 or ndtwo{i}=58 or ndtwo{i}=35 or ndtwo{i}=31 or
ndtwo{i} = 32 or ndtwo{i }~36 or ndtwo{i }=27 or ndtwo{i }=41 or
ndtwo{i} = 82 or ndtwo{i}=85 then output;
end;
PROC SORT DATA= tmpl NODUPKEYS; BY desc;
PROC PRINT DATA= tmpl;

ID;
VAR vartmp 1 desc;
RUN;
Endsas;
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PROGRAM2
PURPOSE : This program gives the list of inappropriate drugs, with dosage
considerations according to Beers criteria.
options obs=max fmtsearch=(work library std_anal.hcfafmts std_anal.mrh_fmts
std_anal.mmarfcmx);
%let alllist = dmpers dmdate nd: IDFROM MXIDO MXIDl MXDATEO MXDATEl
IDGENDR IDRACE ID AGE NCXXCNT DX: PHADLA MDMDSCA CTBLADR
CTCTHIN PHCPS BKASSRB DMTYPE;
data tmp 1sd;
set sagea.sd (in=a keep=&alllist);
if 'O 1-0ct-1995'd<=dmdate<='3 l-dec-1996 'd;
state=" SD";
- _•.,._:

data tmp 1sd; set tmp 1sd;
if idage>=65;

~,

data tmplny;
set sagea.ny (in=a keep=&alllist);
if 'O 1-0ct-1995 'd<=dmdate<='3 l-dec-1996'd;
data tmplny; set tmplny;
if idage>=65;
state="NY";
data tmplms;
set sagea.ms (in=a keep=&alllist);
if 'O 1-0ct-1995'd<=dmdate<='3 l-dec-1996'd;
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state="MS";
(

data tmplms; set tmplms;
if idage>=65;
data tmplme;
set sagea.me(in=a keep=&alllist);
if 'O 1-0ct-1995 'd<=dmdate<='3 l-dec-1996 'd;
data tmplme; set tmplme;
if idage>=65;
state="ME";
data tmplks;
set sagea.ks(in=a keep=&alllist);
if 'O 1-0ct-l 995'd<=dmdate<='3 l-dec-1996'd;
data tmplks; set tmplks;
if idage>=65;

-,,.,

state="KS";
data local.anal; set tmplsd tmplny tmplms tmplme tmplks;

*** define the drug groups;
data tmp; set local.anal;

* Preparation for using MEDISPAN codes;
%let dsc=ndOldsc nd02dsc nd03dsc nd04dsc nd05dsc nd06dsc
nd07dsc nd08dsc nd09dsc ndlOdsc ndl ldsc nd12dsc
nd13dsc ndl4dsc ndl5dsc nd16dsc ndl 7dsc nd18dsc;
%let pm=ndOlpm nd02pm nd03pm nd04pm nd05pm nd06pm

35

nd07pm nd08pm n_d09pm ndlOpm ndllpm ndl2pm

(

nd13pm nd14pm nd15pm nd16pm ndl 7pm nd18pm;
%let frq=ndOlfrq nd02frq nd03frq nd04frq nd05frq nd06frq
nd07frq nd08frq nd09frq ndlOfrq ndl lfrq nd12frq
nd13frq nd14frq nd15frq nd16frq ndl 7frq nd18frq;
array ndsc {18} &dsc;
array ndpm {18} &pm;
array ndfrq {18} &frq;
DO i = 1TO18;
desc=substr(ndsc {i}, 1,35);
pm=ndpm {i};
frq=ndfrq {i };
- .J;/._•

if desc"="

" then output;

end;
keep dmpers dmdate desc frq pm;
PROC SORT DATA= tmp; BY desc;
filename ina 'be_dr.txt';
data drrecode; infile ina;
input @1drugcod2. @3 maxdose 7.3 @10 dose 7.3 @17 unit $1. @18 desc $35.;
proc sort data=drrecode; by desc;
data LOCAL.DRUGS; merge tmp(in=inl) drrecode(in=in2); by desc;
if inl & in2;
array drug propo indom phenyb penta meper dicyc

36

hyoscy propa bella trimet metho cariso oxybut

(

chlor meta cyclo flura lora oxaze alpraz
temaz zolpi tria diaz chlord mepro amitry
doxe diphen diso digo dipyr methyd rese chlopro
chlphen diphy hydro cypro prom trip dexch iron ticlo ;
do over diug;
drug=O; end;
if drugcod=Ol then propo=l; if drugcod=02 then indom=l;
if drugcod=03 then phenyb=l;if drugcod=04 then penta=l;
if drugcod=05 then meper=l ;if drugcod=06 then dicyc=l;
if drugcod=07 then hyoscy=l;if drugcod=08 then propa=l;
if drugcod=09 then bella=l; if drugcod=lO then trimet=l;
if drugcod=l 1 then metho=l; if drugcod=12 then cariso=l;
if drugcod=13 then oxy1'ut=l; if drugcod=l4 then chlor=l;
if drugcod=15 then meta=l; if drugcod=16 then cyclo=l;
if drugcod=l7 then flura=l; if drugcod=l8 then lora=l;
if drugcod=l9 then oxaze=l; if drugcod=20 then alpraz=l;
if drugcod=21 then temaz=l; if drugcod=22 then zolpi=l;
if drugcod=23 then tria=l; if drugcod=24 then diaz=l;
if drugcod=25 then chlord=l; if drugcod=26 then mepro=l;
if drugcod=27 then amitry=l; if drugcod=28 then doxe=l;
if drugcod=29 then diphen=l; if drugcod=31 then diso=l;
if drugcod=32 then digo=l; if drugcod=33 then dipyr=l;
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if drugcod=34 then methyd=l; if drugcod=35 then rese=l;

(
if drugcod=36 then chlopro=l; if drugcod=37 then chlphen=l;
if drugcod=38 then diphy=l; if drugcod=39 then hydro=l;
if drugcod=40 then cypro=l; if drugcod=41 then prom=l;
if drugcod=42 then trip=l; if drugcod=43 then dexch=l;
if drugcod=44 then iron=l; if drugcod=45 then ticlo=l;
newfrq=.;
if frq='lD' or frq='6W' then newfrq=l;
if frq='2D' then newfrq=2;
if frq='3D' or frq='8H' then newfrq=3;
if frq='4D' or frq='6H' then newfrq=4;
if frq='5D' then newfrq=5;
-

i - '

if frq='6D' or frq='4H' then newfrq=6;
if frq='QO' then newfrqll!:l/2;
if frq='lW' then newfrq=l/7;
if frq='2W' then newfrq=217;
if frq='3W' then newfrq=317;
if frq='4W' then newfrq=417;
if frq='5W' then newfrq=517;
if frq='lM' then newfrq=l/30;
if frq='2M' then newfrq=2/30;
if frq=' lH' or frq='C ' then newfrq=24;
if frq='2H' then newfrq=12;
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if frq='3H' then newfrq=8;
(

if frq='PR' and pm=99 then newfrq=.;
if frq='PR' then do;
newfrq=prn/7; end;
daily=newfrq*dose;
if drugcod=l8 and daily>=maxdose then lora=l;
if drugcod=l9 and daily>=maxdose then oxaze=l;
if drugcod=20 and daily>=maxdose then alpraz=l;
if drugcod=21 and daily>=maxdose then temaz=l;
if drugcod=22 and daily>=maxdose then zolpi=l;
if drugcod=23 and daily>=maxdose then tria=l;
if drugcod=32 and daily>maxdose then digo=l;
.........-4(.:

if drugcod=44 and daily>=maxdose then iron=l;
proc freq data=local.drugs;
tables frq pm dose daily;
where drugcod=18;
proc freq data=local.drugs;
tables frq pm dose daily;
where drugcod=l9;
proc freq data=local.dtugs;
tables frq pm dose daily;
where drugcod=20;
proc freq data=local.drugs;
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tables frq pm dose daily;

(
where drugcod=21;
proc freq data=local.drugs;
tables frq pm dose daily;
where drugcod=22;
proc freq data=local.drugs;
tables frq pm dose daily;
where drugcod=23;
proc freq data=local.drugs;
tables frq pm dose daily;
where drugcod=32;
proc freq data=local.drugs;

..... .

~

tables frq pm dose daily;-·
where drugcod=44;

~

proc freq data=local.drugs;
tables propo indom phenyb penta meper dicyc
hyoscy propa bella trimet metho cariso oxybut
chlor meta cyclo flura lora oxaze alpraz
temaz zolpi tria diaz chlord mepro amitry
doxe diphen diso digo dipyr methyd rese chlopro
chlphen diphy hydro cypro prom trip dexch iron ticlo ;
Endsas;

(
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PROGRAM3
PURPOSE: This program tabulates the inappropriate drugs taken at baseline
and at 90 days.
options obs=max fmtsearch=(work library std_anal.hcfafmts std_anal.mrh_fmts
std_anal.mmarfcmx);
** run crefilel.sas first;
**create a file that contains the date of the admitting assessment;
proc sort data=local.anal; by dmpers dmdate;
**define the first assessment;
data first second;
set local.anal; by dmpers;
if first.dmpers then output first;
else output second;
'

**limit it to the first assessment in this window;
** to allow for follow-up;
data first; set first;
if '01-0ct-1995'd<=dmdate<='30-Sep-1996'd;
if dmtype=2;
if state="NY" and (ncxxcnt=. or ncxxcnt=O) then delete;
data second; set second;
keep dmpers dmdate state ncxxcnt;
data tmpfirst; set first;
frstdat=dmdate; keep dmpers frstdat dmdate;
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proc sort data=tmpfirst; by dmpers;

(

proc sort data=second; by dmpers;

** need to define no follow-up assessment in 30days;
data fu nofu; merge tmpfirst(in=inl) second(in=in2); by dmpers;
if inl & in2 then output fu;
if inl & f\in2 then output nofu;
data fu; set fu;
fu30=0;

** no followup in first 30 days;

fu90=0;

** no followup in first 90 days;

ckdays=intck('days' ,frstdat,dmdate);
if 1<=ckdays<=30 then fu30=1;
if 1<=ckdays<=90 then fu90=1;
nofu=O; badny=O;
if state="NY" and dmdate>='01-0CT-1995'd and (ncxxcnt=. or ncxxcnt=O)
then badny=l;
proc sort data=fu; by dmpers;
proc contents data=fu;
proc means noprint data=fu; by dmpers;
var nofu fu30 fu90 badny;
output out=xfu sum=nofu fu30 fu90 badny;
proc contents data=xfu;
data nofu; set nofu; nofu=l; fu30=0; fu90=0;
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data xfu; set xfu nofu;

(

if fu30> 1 then fu30= 1;
if fu90> 1 then fu90= 1;
if badny>l then badny=l;
keep fu30 fu90 nofu badny dmpers;
proc freq; tables nofu fu30*badny fu90*badny;
proc sort data=xfu; by dmpers;
proc sort data=first; by dmpers;
data first; merge first(in=inl) xfu(in=in2); by dmpers; if inl;
proc freq data=first; tables nofu fu30*badny fu90*badny;
** need to attach drugs at admit to "first" dataset;
proc sort data=local.drugs; by dmpers dmdate;
data tmp; set local.drugs';-'·
proc print data=tmp(obsr;;l5);
id dmpers dmdate;
var propo indom phenyb penta meper dicyc hyoscy propa bella trimet metho cariso
oxybut chlor meta cyclo flura lora oxaze alpraz temaz zolpi tria diaz chlord mepro
amitry

doxe diphen diso digo dipyr methyd rese chlopro chlphen diphy hydro cypro prom trip
dexch iron ticlo ;
proc means noprint data=local.drugs; by dmpers dmdate;
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var propo indom phenyb penta meper dicyc hyoscy propa bella trimet metho cariso

(

oxybut chlor meta cyclo flura lora oxaze alpraz temaz zolpi tria diaz chlord mepro
amitry
doxe diphen diso digo dipyr methyd rese chlopro chlphen diphy hydro cypro prom trip
dexch iron ticlo ;
output out=dr sum= var propo indom phenyb penta meper dicyc hyoscy propa bella
trimet metho cariso oxybut chlor meta cyclo flura lora oxaze alpraz temaz zolpi tria
diaz chlord mepro amitry doxe diphen diso digo dipyr methyd rese chlopro chlphen
diphy hydro cypro prom trip dexch iron ticlo ;
proc print data=dr(obs=15);
id dmpers dmdate;
var var propo indom phenyb penta meper dicyc hyoscy propa bella trimet metho
cariso oxybut chlor met;~yclo flura lora oxaze alpraz temaz zolpi tria diaz chlord
mepro amitry

·"

doxe diphen diso digo dipyr methyd rese chlopro chlphen diphy hydro cypro prom trip
dexch iron ticlo ;
data dr; set dr;
array fix var propo indom phenyb penta meper dicyc hyoscy propa bella trimet metho
cariso oxybut chlor meta cyclo flura lora oxaze alpraz temaz zolpi tria diaz chlord
mepro amitry doxe diphen diso digo dipyr methrd rese chlopro chlphen diphy hydro
cypro prom trip dexch iron ticlo ;
do over fix; if fix>=l then fix=l; end;
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keep dmpers dmdate var propo indom phenyb penta meper dicyc hyoscy propa bella
(

trimet metho cariso oxybut chlor meta cyclo flura lora oxaze alpraz temaz zolpi tria
diaz chlord mepro amitry doxe diphen diso digo dipyr methyd rese chlopro chlphen
diphy hydro cypro prom trip dexch iron ticlo ;

proc sort data=dr; by dmpers dmdate;
proc sort data=first; by dmpers dmdate;
data first; merge first(in=inl) dr(in=in2); by dmpers dmdate;
ifinl;
array fix var propo indom phenyb penta meper dicyc hyoscy propa bella trimet metho
cariso oxybut chlor meta cyclo flura lora oxaze alpraz temaz zolpi tria diaz chlord
mepro amitry doxe diphen diso digo dipyr methyd rese chlopro chlphen diphy hydro
. . ....

cypro prom trip dexch iron ticlo ;
if inl & "in2 then do;

"~

do over fix; if fix=. then fix=O; end;
end;
**need to attach drugs at 30 day to "first" dataset;
data sdr; merge tmpfirst(in=inl) dr(in=in2); by dmpers;
if inl & in2;
ckda ys=in tck('days' ,frstdat,dmdate);
if l<=ckdays<=30;
proc sort data=sdr; by dmpers;
proc means noprint data=sdr; by dmpers;

(
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var var propo indom phenyb penta meper dicyc hyoscy propa bella trimet metho

(

cariso oxybut chlor meta cyclo flura lora oxaze alpraz temaz zolpi tria diaz chlord
mepro ami try
doxe diphen diso digo dipyr methyd rese chlopro chlphen diphy hydro cypro prom trip
dexch iron ticlo ;
output out=edr sum= propo3 indom3 phenyb3 penta3 meper3 dicyc3
hyoscy3 propa3 bella3 trimet3 metho3 cariso3 oxybut3
chlor3 meta3 cyclo3 flura3 lora3 oxaze3 alpraz3
temaz3 zolpi3 tria3 diaz3 chlord3 mepro3 amitry3
doxe3 diphen3 diso3 digo3 dipyr3 methyd3 rese3 chlopro3
chlphen3 diphy3 hydro3 cypro3 prom3 trip3 dexch3 iron3 ticlo3 ;
proc print data=edr(obs=l5);
data edr; set edr;
array drugd propo3 indom3 phenyb3 penta3 meper3 dicyc3
hyoscy3 propa3 bella3 trimet3 metho3 cariso3 oxybut3
chlor3 meta3 cyclo3 flura3 lora3 oxaze3 alpraz3
temaz3 zolpi3 tria3 diaz3 chlord3 mepro3 arnitry3
doxe3 diphen3 diso3 digo3 dipyr3 methyd3 rese3 chlopro3
chlphen3 diphy3 hydro3 cypro3 prom3 trip3 dexch3 iron3 ticlo3 ;
do over drugd; if drugd>=l then drugd=l; end;
keep dmpers propo3 indom3 phenyb3 penta3 meper3 dicyc3
hyoscy3 propa3 bella3 trimet3 metho3 cariso3 oxybut3
chlor3 meta3 cyclo3 flura3 lora3 oxaze3 alpraz3
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temaz3 zolpi3 tria3 diaz3 chlord3 mepro3 amitry3

(
doxe3 diphen3 diso3 digo3 dipyr3 methyd3 rese3 chlopro3
chlphen3 diphy3 hydro3 cypro3 prom3 trip3 dexch3 iron3 ticlo3 ;
proc sort data=edr; by dmpers;
proc sort data=first; by dmpers;
data first; merge first(in=inl) edr(in=in2); by dmpers; if inl;
array drugd propo3 indom3 phenyb3 penta3 meper3 dicyc3
hyoscy3 propa3 bella3 trimet3 metho3 cariso3 oxybut3
chlor3 meta3 cyclo3 flura3 lora3 oxaze3 alpraz3
temaz3 zolpi3 tria3 diaz3 chlord3 mepro3 amitry3
doxe3 diphen3 diso3 digo3 dipyr3 methyd3 rese3 chlopro3
chlphen3 diphy3 hydro3 cypro3 prom3 trip3 dexch3 iron3 ticlo3 ;
if inl & "in2 & fu30=1 then do;
do over drugd; if drugd=. then drugd=O; end;
end;

** do it again for 90 days;
proc sort data=dr; by dmpers;
data sdr; merge tmpfirst(in=inl) dr(in=in2); by dmpers;
if inl & in2;
ckdays=intck('days',frstdat,dmdate);
if 1<=ckdays<=90;
proc sort data=sdr; by dmpers;
proc means noprint data=sdr; by dmpers;
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var propo indom phenyb penta meper dicyc
hyoscy propa bella trimet metho cariso oxybut
chlor meta cyclo flura lora oxaze alpraz
temaz zolpi tria diaz chlord mepro amitry
doxe diphen diso digo dipyr methyd rese chlopro
chlphen diphy hydro cypro prom trip dexch iron ticlo ;
output out=mdr sum=propo9 indom9 phenyb9 penta9 meper9 dicyc9
hyoscy9 propa9 bella9 trimet9 metho9 cariso9 oxybut9
chlor9 meta9 cyclo9 flura9 lora9 oxaze9 alpraz9
temaz9 zolpi9 tria9 diaz9 chlord9 mepro9 amitry9
doxe9 diphen9 diso9 digo9 dipyr9 methyd9 rese9 chlopro9
chlphen9 diphy9 hydro9 cypro9 prom9 trip9 dexch9 iron9 ticlo9 ;
data mdr; set mdr;
array drugd propo9 inddtn9 phenyb9 penta9 meper9 dicyc9
hyoscy9 propa9 bella9 trimet9 metho9 cariso9 oxybut9
chlor9 meta9 cyclo9 flura9 lora9 oxaze9 alpraz9
temaz9 zolpi9 tria9 diaz9 chlord9 mepro9 amitry9
doxe9 diphen9 diso9 digo9 dipyr9 methyd9 rese9 chlopro9
chlphen9 diphy9 hydro9 cypro9 prom9 trip9 dexch9 iron9 ticlo9 ;
do over drugd; if drugd>=l then drugd=l; end; .
keep dmpers propo9 indom9 phenyb9 penta9 meper9 dicyc9
hyoscy9 propa9 bella9 trimet9 metho9 cariso9 oxybut9
chlor9 meta9 cyclo9 flura9 lora9 oxaze9 alpraz9

(
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temaz9 zolpi9 tria? diaz9 chlord9 mepro9 amitry9
doxe9 diphen9 diso9 digo9 dipyr9 methyd9 rese9 chlopro9
chlphen9 diphy9 hydro9 cypro9 prom9 trip9 dexch9 iron9 ticlo9 ;
proc sort data=mdr; by dmpers;
proc sort data=first; by dmpers;
data local.sample; merge first(in=inl) mdr(in=in2); by dmpers;
if inl;
array drugd propo9 indom9 phenyb9 penta9 meper9 dicyc9
hyoscy9 propa9 bella9 trimet9 metho9 cariso9 oxybut9
chlor9 meta9 cyclo9 flura9 lora9 oxaze9 alpraz9
temaz9 zolpi9 tria9 diaz9 chlord9 mepro9 amitry9
doxe9 diphen9 diso9 digo9 dipyr9 methyd9 rese9 chlopro9
chlphen9 diphy9 hydro9 cypro9 prom9 trip9 dexch9 iron9 ticlo9 ;
if inl & "in2 & fu90=1 lhen do;
do over drugd; if drugd=. then drugd=O; end;
end;

** fix for NEW YORK;
do over drugd; if badny=l then drugd=.; end;

** new variable for anybeers;
anybeer9=0;
do over drugd; if drugcl>=l then anybeer9=1; end;
if badny=l or nofu=l or fu90=o then anybeer9=.;
array druge propo3 indom3 phenyb3 penta3 meper3 dicyc3
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hyoscy3 propa3 bella3 trimet3 metho3 cariso3 oxybut3

(
chlor3 meta3 cyclo3 flura3 lora3 oxaze3 alpraz3
temaz3 zolpi3 tria3 diaz3 chlord3 mepro3 amitry3
doxe3 diphen3 diso3 digo3 dipyr3 methyd3 rese3 chlopro3
chlphen3 diphy3 hydro3 cypro3 prom3 trip3 dexch3 iron3 ticlo3 ;

** fix for NEW YORK;
do over druge; if badny=l then druge=.; end;

*** new variable for anybeers;
anybeer3=0;
do over druge; if druge>=l then anybeer3=1; end;
if badny=l or nofu=l or fu30=0 then anybeer3=.;
anybeer=O;
array drugf propo indom:phenyb penta meper dicyc
hyoscy propa bella trimet metho cariso oxybut
chlor meta cyclo flura lora oxaze alpraz
temaz zolpi tria diaz chlord mepro amitry
doxe diphen diso digo dipyr methyd rese chlopro
chlphen diphy hydro cypro prom trip dexch iron ticlo;

** fix for NEW YORK;
** new variable for anybeers;
anybeer=O;
do over drugf; if drugf>=l then anybeer=l; end;
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do over drugf;

(
if state="NY" and dmdate>='O 1-0CT-1995'd and (ncxxcnt=. or ncxxcnt=O)
then drugf=.;
end;
proc contents data=local.sample;
proc freq data=local.samp°Ie;
tables nofu fu30 fu90 propo indom phenyb penta meper dicyc
hyoscy propa bella trimet metho cariso oxybut
chlor meta cyclo flura lora oxaze alpraz
temaz zolpi tria diaz chlord mepro amitry
doxe diphen diso digo dipyr methyd rese chlopro
chlphen diphy hydro cypro prom trip dexch iron ticlo
propo3 indom3 phenyb3 penta3 meper3 dicyc3
hyoscy3 propa3 5ella3 trimet3 metho3 cariso3 oxybut3
chlor3 meta3 cyclo3 flura3 lora3 oxaze3 alpraz3
temaz3 zolpi3 tria3 diaz3 chlord3 mepro3 amitry3
doxe3 diphen3 diso3 digo3 dipyr3 methyd3 rese3 chlopro3
chlphen3 diphy3 hydro3 cypro3 prom3 trip3 dexch3 iron3 ticlo3
propo9 indom9 phenyb9 penta9 meper9 dicyc9
hyoscy9 propa9.bella9 trimet9 metho9 ca!iso9 oxybut9
chlor9 meta9 cyclo9 flura9 lora9 oxaze9 alpraz9
temaz9 zolpi9 tria9 diaz9 chlord9 mepro9 amitry9
doxe9 diphen9 diso9 digo9 dipyr9 methyd9 rese9 chlopro9

(
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chlphen9 diphy9 hydro9 cypro9 prom9 trip9 dexch9 iron9 ticlo9

(
anybeer anybeer3 anybeer9;
** check bias;
proc freq data=local.sample;
tables ( propo indom phenyb penta meper dicyc
hyoscy propa bella trimet nietho cariso oxybut
chlor meta cyclo flura lora oxaze alpraz
temaz zolpi tria diaz chlord mepro amitry
doxe diphen diso digo dipyr methyd rese chlopro
chlphen diphy hydro cypro prom trip dexch iron ticlo)*fu30;
proc freq data=local.sample;
tables propo*propo3 indom*indom3 phenyb*phenyb3 penta*penta3
meper*meper3 dicyc*dicyc3
hyoscy*hyoscy3 {tropa*propa3 bella*bella3 trimet*trimet3
metho*metho3 cariso*cariso3 oxybut*oxybut3
chlor*chlor3 meta*meta3 cyclo*cyclo3 flura*flura3
lora*lora3 oxaze*oxaze3 alpraz*alpraz3
temaz*temaz3 zolpi*zolpi3 tria*tria3 diaz*diaz3 chlord*chlord3
mepro*mepro3 amitry*amitry3
doxe*doxe3 diphen*diphen3 diso*diso3

~igo*digo3

dipyr*dipyr3 methyd*methyd3 rese*rese3 chlopro*chlopro3
chlphen*chlphen3 diphy*diphy3 hydro*hydro3
cypro*cypro3 prom*prom3 trip*trip3 dexch*dexch3 iron*iron3

(
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ticlo*ticlo3 anybeer*anybeer3

(
propo*propo9 indom*indom9 phenyb*phenyb9 penta*penta9
meper*meper9 dicyc*dicyc9
hyoscy*hyoscy9 propa*propa9 bella*bella9 trimet*trimet9
metho*metho9 cariso*cariso9 oxybut*oxybut9
chlor*chlor9 meta*meta9 cyclo*cyclo9 flura*flura9
lora*lora9 oxaze*oxaze9 alpraz*alpraz9
temaz*temaz9 zolpi*zolpi9 tria*tria9 diaz*diaz9 chlord*chlord9
mepro*mepro9 amitry*amitry9
doxe*doxe9 diphen*diphen9 diso*diso9 digo*digo9
dipyr*dipyr9 methyd*methyd9 rese*rese9 chlopro*chlopro9
chlphen*chlphen9 diphy*diphy9 hydro*hydro9
cypro*cypro9 prom*prom9 trip*trip9 dexch*dexch9 iron*iron9
ticlo*ticlo9 anybeer*anybeer9/ missprint;
Endsas;
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PROGRAM4

(
PURPOSE: This program creates variables for sociodemographic characteristics
and tabulates them.
options obs=max fmtsearch=(work library std_anal.hcfafmts std_anal.mrh_fmts
std_anal.mmarfcmx);

** run crefilel .sas first;
** create a file that contains the date of the admitting assessment;
data new; set local.sample;
if anybeer9=. then delete;
numinapp=O;
array summit propo9 indom9 phenyb9 penta9 meper9 dicyc9
hyoscy9 propa9 bella9 trimet9 metho9 cariso9 oxybut9
- .'-.;.._~.

chlor9 meta9 cyclo9 flura9 lora9 oxaze9 alpraz9
temaz9 zolpi9 tria9 diaz9 chlord9 mepro9 arnitry9
doxe9 diphen9 diso9 digo9 dipyr9 methyd9 rese9 chlopro9
chlphen9 diphy9 hydro9 cypro9 prom9 trip9 dexch9 iron9 ticlo9 ;
do over summit;
numinapp=summit+numinapp;
end;
highsev9=0;
array high penta9 meper9 dicyc9 hyoscy9 propa9 bella9 flura9 diaz9 chlord9 mepro9
amitry9 doxe9 diso9 digo9 methyd9 chlopro9 ticlo9;
do over high;
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if high>=l then highsev9=1; end;

(

**prepare data for models;
female=O; misssex=O;
if idgendr=2 then female=!;
if idgendr=. then misssex=l;
agecat=.;
if .<idage<=64 then agecat=O;
if 65<=idage<=74 then agecat=l;
if 75<=idage<=84 then agecat=2;
if idage>=85 then agecat=3;
age7584=0;age85=0;
if 75<=idage<=84 then age7584=1;
if idage>=85 then ageSS~l;
black=O; white=O; othrace=O; missrace=O;
if idrace=5 then white=!;
if idrace=3 then black=!;
if idrace=l or idrace=2 or idrace=4 then othrace=l;
if idrace=. then missrace=l;
**recoding cognitive function;
if O<=phcps<=l then cogfncat = 1;
if 2<=phcps<=4 then cogfncat = 2;
if 5<=phcps<=6 then cogfncat = 3;
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*recoding physical function;

(
if O<=phadla<=l then phfuncat = 1;
if 2<=phadla<=3 then phfuncat = 2;
if 4<=phadla<=5 then phfuncat = 3;
cps24=0;cps56=0;rnisscps=O;
if cogfncat=2 then cps24=1;
if cogfncat=3 then cps56=1;
if phcps=. then rnisscps=l;
*recoding physical function;
adl23=0; adl45=0; rnissadl=O;
if phfuncat=2 then adl23= 1;
if phfuncat=3 then adl45=1;

-..

if phadla=. then missadl;-1;
home=O; hosp=O; oth=Ot.rnissfrom=O;
if idfrom=l then home=l;
if idfrom=3 then hosp=l;
if idfrom=2 or idfrom=4 then oth=l;
if idfrom=. then rnissfrom=l;
proc freq data=new;
tables (idgendr agecat idrace numinapp id.from phfuncat cogfncat)*
(anybeer9 highsev9) I chisq;
Endsas;

(
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SECTION III

(
Minimum Data Set (MDS)

~·-~.
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